马尔凡综合征的治疗机会:当前的前景
Xiaoying Feng1, Chao Qu2, Ping Jia3
1College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Drug design, development and therapy
|September 3, 2025
概括
玛凡综合症 (MFS) 是一种影响结合组织的遗传性疾病,通过新技术越来越多地被了解. 研究正在推进包括基因疗法在内的治疗策略,
科学领域:
- 遗传学
- 分子生物学
- 心血管医学
背景情况:
- 马方综合症 (MFS) 是一种由纤维素-1 (FBN1) 基因突变引起的遗传性结合组织疾病.
- 它影响多个器官系统,特别是眼睛,骨和心血管系统,后者具有最大的死亡风险.
- 目前的治疗重点是控制症状并预防危及生命的心血管事件.
研究的目的:
- 为了回顾马芬综合症治疗的最新进展.
- 突出新兴的治疗目标和创新的治疗方法.
- 讨论MFS基因治疗的可能性.
主要方法:
- 对马方综合征治疗的最新文献的综述.
- 对CRISPR-Cas9和诱导多能干细胞 (iPSC) 等新兴技术的分析.
- 探索新药发现平台和个性化治疗方法.
主要成果:
- 新技术正在加深对FBN1突变多样性和疾病机制的理解.
- CRISPR-Cas9和iPSC为药物发现和个性化医疗提供了有前途的途径.
- 手术创新和新的药理目标正在改善MFS的管理.
结论:
- 马芬综合征的近期治疗进展包括手术和药物方面的进步.
- 新兴技术正在为个性化治疗和更好地了解疾病铺平道路.
- 基因疗法对治疗马方综合征具有显著的未来潜力.
相关概念视频
Cystic Fibrosis: Management
222
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
222
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Aneurysm I: Introduction
25
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
25
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32


